What Kathy Ireland Says Brands Are Getting Wrong About Millennials
Charlotte-based marketing and branding company Level Brands just went public on the NYSE Friday, then closed Monday at $5.41, below its opening price of $6. In the Regulation A+ IPO, Level Brands raised nearly $12 million. Kathy Ireland, Chief Brand Strategist and Chairman Emeritus at the company, says Level Brands is using the funding for brand development and expansion for companies it believes in.
Ireland says brands that struggle to reach millennials don't listen. Today, millennials are demanding transparency. As a result, the most transparent brands are the most successful according to Ireland.
In September, Level Brands licensed kathy ireland® Health & Wellness. Other Level Brand business units include Beauty & Pin-Ups, Ireland Men One, and Encore Endeavor One. Ireland says she's encouraged by the initial days of trading on the NYSE. Bringing democracy from Wall Street to main street was important to Level Brands in this IPO, says Ireland.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
